Isatuximab in Combination With Novel Agents in RRMM - Master Protocol

Clinical trial NCT04643002 · RECRUITING

Trial details

NCT number: NCT04643002
Sponsor: Sanofi
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Plasma Cell Myeloma Refractory

Start date: 2021-01-25
Primary completion: 2027-09-13
Enrollment: 258

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.